Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

B. Aktas · SciRah

Researcher profile · Semantic Scholar

B. Aktas

Share profile

B. Aktas — researcher profile on SciRah

h-index: 38
Works: 400
Citations: 6,650

Most-cited papers

Changes in Tissue Fluidity Predict Tumor Aggressiveness In Vivo
F. Sauer, Steffen Grosser, Mehrgan Shahryari, A. Hayn +8 more
2023Advancement of science53 citations Open access
Semantic Scholar
State of Cell Unjamming Correlates with Distant Metastasis in Cancer Patients
P. Gottheil, Jürgen Lippoldt, Steffen Grosser, F. Renner +15 more
2023Physical Review X39 citations Open access
Semantic Scholar
De-Escalated Neoadjuvant Trastuzumab-Emtansine With or Without Endocrine Therapy Versus Trastuzumab With Endocrine Therapy in HR+/HER2+ Early Breast Cancer: 5-Year Survival in the WSG-ADAPT-TP Trial
N. Harbeck, U. Nitz, M. Christgen, S. Kuemmel +23 more
2023Journal of Clinical Oncology35 citations
Semantic Scholar
Effect of home-based online training and activity feedback on oxygen uptake in patients after surgical cancer therapy: a randomized controlled trial
R. Falz, Christian Bischoff, R. Thieme, U. Tegtbur +12 more
2023BMC Medicine25 citations Open access
Semantic Scholar
Desmoplasia in cervical cancer is associated with a more aggressive tumor phenotype
Benjamin Wolf, L. Weydandt, N. Dornhöfer, Grit Gesine Ruth Hiller +5 more
2023Scientific Reports21 citations Open access
Semantic Scholar
Oncologic outcomes after Total Mesometrial Resection (TMMR) or treatment according to current international guidelines in FIGO (2009) stages IB1-IIB cervical cancer: an observational cohort study
Henrik Falconer, Anna Norberg-Hardie, Sahar Salehi, Emilia Alfonzo +5 more
2024EClinicalMedicine15 citations Open access
Semantic Scholar
Molecular Subtypes of Vulvar Squamous Cell Carcinoma: The Significance of HPV-Independent/p53 Wild Type
Lars-Christian Horn, Christine E. Brambs, B. Gilks, Ho-Ang Lien +9 more
2024Cancers15 citations Open access
Semantic Scholar
HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN
Gilda Schmidt, O. Gluz, M. Christgen, M. Reinisch +26 more
2025Breast Cancer Research11 citations Open access
Semantic Scholar
Human Papilloma Virus–Independent/p53abnormal Keratinizing Squamous Cell Carcinoma of the Uterine Cervix Associated With Uterine Prolapse
Lars-Christian Horn, C. E. Brambs, B. Aktas, Astrid Dannenmann +8 more
2024International Journal of Gynecological Pathology11 citations
Semantic Scholar
The Challenge to Stabilize, Extract and Analyze Urinary Cell-Free DNA (ucfDNA) during Clinical Routine
I. Nel, Carolin Münch, Saikal Shamkeeva, Mitja L. Heinemann +2 more
2023Diagnostics11 citations Open access
Semantic Scholar
Different contractility modes control cell escape from multicellular spheroids and tumor explants
Eliane Blauth, Steffen Grosser, Frank Sauer, Mario Merkel +10 more
2024APL Bioengineering10 citations Open access
Semantic Scholar
Recommendations for the diagnosis and treatment of patients with early breast cancer: update 2023
Melitta Köpke, B. Aktas, N. Ditsch
2023Current Opinion in Obstetrics and Gynecology10 citations
Semantic Scholar
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole.
P. Fasching, C. Hack, N. Nabieva, Nicolai Maass +38 more
2024European Journal of Cancer9 citations Open access
Semantic Scholar
Update Breast Cancer 2024 Part 1 – Expert Opinion on Advanced Breast Cancer
R. Würstlein, H. Kolberg, A. Hartkopf, T. Fehm +26 more
2024Geburtshilfe und Frauenheilkunde9 citations Open access
Semantic Scholar
Update Breast Cancer 2023 Part 2 – Advanced-Stage Breast Cancer
M. Lux, A. Hartkopf, T. Fehm, M. Welslau +26 more
2023Geburtshilfe und Frauenheilkunde8 citations Open access
Semantic Scholar
CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs
A. Schneeweiss, S. Brucker, H. Huebner, L. Volmer +32 more
2023Geburtshilfe und Frauenheilkunde8 citations Open access
Semantic Scholar
Update Breast Cancer 2024 Part 2 – Patients with Early Stage Breast Cancer
W. Janni, H. Kolberg, A. Hartkopf, T. Fehm +27 more
2024Geburtshilfe und Frauenheilkunde7 citations Open access
Semantic Scholar
Self organisation of invasive breast cancer driven by the interplay of active and passive nematic dynamics
P. Gottheil, S. Bhattacharyya, Kolya Lettl, Philip Friedrich +11 more
2024bioRxiv7 citations Open access
Semantic Scholar
Multi-Parameter Analysis of Disseminated Tumor Cells (DTCs) in Early Breast Cancer Patients with Hormone-Receptor-Positive Tumors
T. König, Senol Dogan, A. Höhn, L. Weydandt +2 more
2023Cancers7 citations Open access
Semantic Scholar
Update Breast Cancer 2023 Part 3 – Expert Opinions of Early Stage Breast Cancer Therapies
H. Kolberg, A. Hartkopf, T. Fehm, M. Welslau +26 more
2023Geburtshilfe und Frauenheilkunde7 citations Open access
Semantic Scholar
Immunomodulatory gene networks predict treatment response and survival to de-escalated, anthracycline-free neoadjuvant chemotherapy in triple-negative breast cancer in the WSG-ADAPT-TN trial
D. Korbie, C. Stirzaker, O. Gluz, C. zu Eulenburg +18 more
2025Molecular Cancer6 citations Open access
Semantic Scholar
Update Breast Cancer 2024 Part 3 – Patients with Advanced Stage Breast Cancer
D. Lüftner, H. Kolberg, A. Hartkopf, T. Fehm +27 more
2024Geburtshilfe und Frauenheilkunde6 citations Open access
Semantic Scholar
Update Breast Cancer 2023 Part 1 – Early Stage Breast Cancer
A. Hartkopf, T. Fehm, M. Welslau, V. Müller +26 more
2023Geburtshilfe und Frauenheilkunde6 citations Open access
Semantic Scholar
Real-world utilization of aromatase inhibitors, tamoxifen, and ovarian function suppression in premenopausal patients with early hormone receptor-positive, HER2-negative breast cancer with increased recurrence risk
V. Müller, Manuel Hörner, M. Thill, M. Banys-Paluchowski +31 more
2025Breast5 citations Open access
Semantic Scholar
Lower extremity lymphedema in patients with gynecologic cancer: Validation of the Gynecologic Cancer Lymphedema Questionnaire (GCLQ) in German language and investigation of lymphedema real-world treatment
Henrike Meyer, Andreas Hinz, Christiane Weisgerber, Adrian Pilny +4 more
2024Archives of Gynecology and Obstetrics5 citations Open access
Semantic Scholar
Anatomy of the fetal membranes: insights from spinning disk confocal microscopy
H. M. Eichholz, Alissa Cornelis, Benjamin Wolf, Hanna Grubitzsch +5 more
2023Archives of Gynecology and Obstetrics5 citations Open access
Semantic Scholar
Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
C. Hack, Nicolai Maass, B. Aktas, S. Kümmel +39 more
2023Geburtshilfe und Frauenheilkunde5 citations Open access
Semantic Scholar
Use of a microsurgical vascular clip system for temporary bilateral occlusion of the four main uterine vessels for laparoscopic enucleation of very large intramural uterine fibroids
S. Younes, M. Radosa, A. Schneider, J. Radosa +3 more
2022Archives of Gynecology and Obstetrics5 citations Open access
Semantic Scholar
Risk Factors for Surgical Wound Infection and Fascial Dehiscence After Open Gynecologic Oncologic Surgery: A Retrospective Cohort Study
Carolin Hagedorn, N. Dornhöfer, B. Aktas, L. Weydandt +1 more
2024Cancers3 citations Open access
Semantic Scholar
A Single-Centre Retrospective Analysis of Pregnancies with Placenta Accreta Spectrum (PAS): From One-Step Surgery towards Two-Step Surgical Approach
L. Weydandt, Massimiliano Lia, Amanda Schöne, J. Hoffmann +3 more
2024Journal of Clinical Medicine3 citations Open access
Semantic Scholar
Preventive Measures for Patients With an Elevated Genetic Risk for Gynecological Malignancies, in Particular Familial Breast and Ovarian Cancer.
N. Ditsch, B. Aktas, M. Banys-Paluchowski, D. Speiser +2 more
2025Deutsches Ärzteblatt International2 citations
Semantic Scholar
Characterization of Disseminated Tumor Cells (DTCs) in Patients with Triple-Negative Breast Cancer (TNBC)
Anne Eckardt, I. Nel, L. Weydandt, Elisa Brochwitz +3 more
2025Cells2 citations Open access
Semantic Scholar
MRI Texture Analysis of Inguinal Lymph Node Metastasis in Vulvar Cancer – Associations With Histopathology
Jakob Leonhardi, Lars-Christian Horn, B. Aktas, T. Denecke +2 more
2024Anticancer Research2 citations
Semantic Scholar
Refining Risk Assessment for Adjuvant CDK4/6 Inhibitors beyond Trial Inclusion Criteria: Integrating Recurrence Score and Endocrine Responsiveness according to ADAPT
M. Braun, O. Gluz, S. Kuemmel, U. Nitz +17 more
2026Breast Care1 citations Open access
Semantic Scholar
Predicting the Need for Surgery in Tubo-Ovarian Abscess: A Clinical Evaluation and External Validation of Risk Scores.
A. Baer, Massimiliano Lia, Christiane Weisgerber, B. Aktas +1 more
2026Journal of minimally invasive gynecology1 citations Open access
Semantic Scholar
Influencing factors on seroma formation following mastectomy: a retrospective cohort study
Karl Hein, L. Weydandt, Massimiliano Lia, Senol Dogan +3 more
2026World Journal of Surgical Oncology1 citations Open access
Semantic Scholar
Spectrum of double heterozygosity in individuals diagnosed with hereditary breast and ovarian cancer.
N. Herold, Christoph Engel, D. Speiser, T. Ripperger +34 more
2026European Journal of Cancer1 citations Open access
Semantic Scholar
Experiences and expectations of advance directives in gynecological cancer patients (the NOGGO-expression X study).
Melisa Guelhan Inci, Ebru İlter, E. Roser, D. Dimitrova +21 more
2025International Journal of Gynecological Cancer1 citations Open access
Semantic Scholar
Patient-Reported Outcomes With Pembrolizumab Plus Chemoradiotherapy For High-Risk, Locally Advanced Cervical Cancer: Interim Analysis 2 Results From The Randomised, Double-Blind, Phase 3 ENGOT-Cx11/GOG-3047/KEYNOTE-A18 Study
V. Sukhin, V. Salutari, R. Lazzari, J. Korach +16 more
2025International Journal of Gynecological Cancer1 citations
Semantic Scholar
Preoperative conization in cervical cancer patients undergoing open abdominal radical hysterectomy: Results from a propensity-score matched study.
Benjamin Wolf, D.S. Trantaki, Lars-Christian Horn, B. Aktas +1 more
2025Gynecologic Oncology1 citations
Semantic Scholar
Abstract P2-11-27: Peritumoral desmoplasia in breast cancer – does it matter?
L. Weydandt, Benjamin Wolf, L. Horn, B. Aktas
2023Cancer Research1 citations
Semantic Scholar
Systemic Therapy of Premenopausal Patients with Early Stage Hormone Receptor-Positive, HER2-Negative Breast Cancer – Controversies and Standards in Healthcare
V. Müller, P. Fasching, N. Nabieva, T. Fehm +15 more
2023Geburtshilfe und Frauenheilkunde1 citations Open access
Semantic Scholar
Disseminated Tumor Cells (DTCs) in Patients with Cervical Cancer Reveal Mesenchymal Properties and Potential Therapeutic Targets—A New Perspective?
Elisa Brochwitz, I. Nel, Anne Eckardt, L. Weydandt +3 more
2026International Journal of Molecular Sciences0 citations Open access
Semantic Scholar
Case report: a rare BRCA1 de novo variant in a female with breast cancer
C. Dencker, V. Strehlow, B. Aktas, Johannes R. Lemke +1 more
2026Hereditary Cancer in Clinical Practice0 citations Open access
Semantic Scholar
Peripheral immune network-directed dissection of lymph node regions (iLND): Novel surgical approach for the regional assessment and therapy of vulvar carcinoma.
M. Höckel, L. Weydandt, Benjamin Wolf, Eman Abdel Keream +7 more
2026Gynecologic Oncology0 citations Open access
Semantic Scholar
Surgical care of patients with primary advanced ovarian cancer – results from the 3rd interim analysis of the prospective, non-interventional SCOUT-1 study (NOGGO ov54, NCT04830709).
J. Sehouli, E. Braicu, K. Pietzner, J. Goldmann +17 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Microsatellite instability status and mismatch repair defects testing in endometrial cancer - insights from the multicenter E-PEC trial
Büşra Eser, D. Papior, Jon Salmanton-García, B. Morgenstern +11 more
2026International Journal of Gynecological Cancer0 citations
Semantic Scholar
Abstract 7838: Innovative biomarker discovery: A non-invasive, comprehensive tumor characterization approach with plasma and urine from breast cancer patients.
I. Nel, Ekaterina Firsova, L. Weydandt, B. Aktas
2026Cancer Research0 citations
Semantic Scholar
Atezolizumab neoadjuvant mit Vorteil für das Langzeitüberleben
L. Weydandt, B. Aktas
2026InFo Hämatologie + Onkologie0 citations
Semantic Scholar
Tumor mutations predict HER2-targeted therapy resistance in primary HER2-positive breast cancer
M. V. van Mackelenbergh, N. Pfarr, K. Weber, M. Untch +21 more
2026npj Breast Cancer0 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

L. Weydandt×13
Invite
L. Weydandt — researcher profile on SciRah
N. Ditsch×12
Invite
N. Ditsch — researcher profile on SciRah
T. Fehm×12
Invite
T. Fehm — researcher profile on SciRah
Benjamin Wolf×11
Invite
Benjamin Wolf — researcher profile on SciRah

×11

Invite

V. Müller — researcher profile on SciRah

E. Belleville×11

Invite

E. Belleville — researcher profile on SciRah

Invite

H. Kolberg — researcher profile on SciRah

Invite

A. Hartkopf — researcher profile on SciRah

M. Banys-Paluchowski×9

Invite

M. Banys-Paluchowski — researcher profile on SciRah

N. Dornhöfer×8

Invite

N. Dornhöfer — researcher profile on SciRah

Invite

I. Nel — researcher profile on SciRah

E. Stickeler×8

Invite

E. Stickeler — researcher profile on SciRah